当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 现金流量表

金城医药

(300233)

  

流通市值:42.44亿  总市值:43.76亿
流通股本:3.72亿   总股本:3.84亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,680,369,204.921,147,973,075.64585,641,780.022,345,797,951.18
  收到的税费返还3,890,889.872,909,031.11936,341.9510,226,971.33
  收到其他与经营活动有关的现金24,155,583.1418,434,520.967,615,216.7166,431,337.31
  经营活动现金流入小计1,708,415,677.931,169,316,627.71594,193,338.682,422,456,259.82
  购买商品、接受劳务支付的现金617,269,998.63406,192,029.73200,902,843.86860,701,758.11
  支付给职工以及为职工支付的现金424,465,296.95299,599,079.3174,769,301.62591,082,789.77
  支付的各项税费147,251,240.41114,441,021.6754,098,500.94205,870,894.6
  支付其他与经营活动有关的现金249,540,226.97155,309,249.6176,920,695.12445,160,776.08
  经营活动现金流出小计1,438,526,762.96975,541,380.31506,691,341.542,102,816,218.56
  经营活动产生的现金流量净额269,888,914.97193,775,247.487,501,997.14319,640,041.26
二、投资活动产生的现金流量:
  取得投资收益收到的现金---1,200,000
  处置固定资产、无形资产和其他长期资产收回的现金净额41,226,701.6840,423,308.2835,276,75023,788,023.2
  收到的其他与投资活动有关的现金1,949,606,240.651,448,489,360.68563,175,953.611,456,950,656.53
  投资活动现金流入小计1,990,832,942.331,488,912,668.96598,452,703.611,481,938,679.73
  购建固定资产、无形资产和其他长期资产支付的现金63,905,015.0341,445,945.5228,113,567.01100,883,345.29
  投资支付的现金3,000,000---
  支付其他与投资活动有关的现金2,014,100,0001,364,100,000662,100,0001,537,011,200
  投资活动现金流出小计2,081,005,015.031,405,545,945.52690,213,567.011,637,894,545.29
  投资活动产生的现金流量净额-90,172,072.783,366,723.44-91,760,863.4-155,955,865.56
三、筹资活动产生的现金流量:
  吸收投资收到的现金11,549.79---
  其中:子公司吸收少数股东投资收到的现金11,549.79---
  取得借款收到的现金140,000,00094,000,00060,000,000137,975,000
  筹资活动现金流入小计140,011,549.7994,000,00060,000,000137,975,000
  偿还债务支付的现金301,285,000137,785,000102,500,000272,030,193.26
  分配股利、利润或偿付利息支付的现金62,511,041.8560,865,813.951,962,169.53162,507,415.06
  支付其他与筹资活动有关的现金1,302,566.03744,240589,0002,136,464.96
  筹资活动现金流出小计365,098,607.88199,395,053.95105,051,169.53436,674,073.28
  筹资活动产生的现金流量净额-225,087,058.09-105,395,053.95-45,051,169.53-298,699,073.28
四、汇率变动对现金及现金等价物的影响-2,734,974.63-1,863,133.93-860,202.481,843,586.64
五、现金及现金等价物净增加额-48,105,190.45169,883,782.96-50,170,238.27-133,171,310.94
  加:期初现金及现金等价物余额745,312,799.46745,312,799.46745,312,799.46878,484,110.4
  期末现金及现金等价物余额697,207,609.01915,196,582.42695,142,561.19745,312,799.46
补充资料:
  净利润-141,492,562.53-42,273,760.23
  资产减值准备-40,725,721.44-55,662,378.95
  固定资产和投资性房地产折旧-122,388,099.3-249,234,152.58
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-122,388,099.3-249,234,152.58
  无形资产摊销-37,196,284.29-69,760,607.52
  长期待摊费用摊销-1,552,570.92-3,157,542.65
  处置固定资产、无形资产和其他长期资产的损失--47,831,639.42--2,948,972.26
  固定资产报废损失-366,601.58-1,088,583.68
  公允价值变动损失-117,247.22-86,057.68
  财务费用-10,504,328.25-11,288,052.4
  投资损失--23,875,917.53--2,787,697.93
  递延所得税-2,012,730.09--2,622,659.53
  其中:递延所得税资产减少-10,192,346.42-16,335,959.18
    递延所得税负债增加--8,179,616.33--18,958,618.71
  存货的减少--32,255,172.01-101,367,946.3
  经营性应收项目的减少-6,335,754.06-58,167,638.44
  经营性应付项目的增加--65,671,750.63--263,480,657.47
  现金的期末余额-915,196,582.42-745,312,799.46
  减:现金的期初余额-745,312,799.46-878,484,110.4
  现金及现金等价物的净增加额-169,883,782.96--133,171,310.94
公告日期2026-10-292026-08-212026-04-242026-03-27
审计意见(境内)标准无保留意见
TOP↑